ADC Therapeutics SA Total Assets 2019-2022 | ADCT

ADC Therapeutics SA total assets from 2019 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
ADC Therapeutics SA Annual Total Assets
(Millions of US $)
2021 $618
2020 $514
2019 $138
2018 $151
ADC Therapeutics SA Quarterly Total Assets
(Millions of US $)
2022-06-30 $520
2022-03-31 $582
2021-12-31 $618
2021-09-30 $638
2021-06-30 $464
2021-03-31 $462
2020-12-31 $514
2020-09-30 $522
2020-06-30 $374
2020-03-31 $0
2019-12-31 $0
2019-09-30 $0
2019-06-30 $0
2018-12-31 $151
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.376B $0.034B
ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company. It engages in development and commercialization of antibody drug conjugates for patients suffering from hematological malignancies and solid tumors. ADC Therapeutics SA is based in LAUSANNE, Switzerland.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $150.984B 9.16
GSK (GSK) United Kingdom $59.709B 7.17
Bio-Rad Laboratories (BIO.B) United States $12.433B 27.47
Biohaven Pharmaceutical Holding (BHVN) United States $10.873B 0.00
QIAGEN (QGEN) Netherlands $9.383B 15.71
Ginkgo Bioworks Holdings (DNA) United States $4.998B 0.00
Arcus Biosciences (RCUS) United States $1.819B 35.51
Myovant Sciences (MYOV) United Kingdom $1.614B 0.00
Emergent Biosolutions (EBS) United States $1.040B 6.03
Zymeworks (ZYME) Canada $0.305B 0.00
Enzo Biochem (ENZ) United States $0.105B 0.00
Gelesis Holdings (GLS) United States $0.081B 0.00
SQZ Biotechnologies (SQZ) United States $0.068B 0.00
Ambrx Biopharma (AMAM) United States $0.041B 0.00